General Atlantic-backed biotech start-up secures $410mn in initial funding round
The Series A funding round by the start-up, co-founded by executives of Aiolos Bio, the biotech that was sold to GSK last ...
The future of QT
Unhedged has not written about QT in a while for a simple reason: it’s been working. After QT contributed to 2019’s repo crisis, many feared that the newest QT cycle, started in 2022, may lead to ...